In contrast, DJ-1 is known as an oncoprotein and loss of DJ-1 is predicted to inhibit cancer growth, thus the loss of DJ-1 in PD patients is theoretically not a reason to contribute to cancer development. This evidence concerns the gene PARK7 and Parkinson disease.